24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Mapi Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:32
From $200 million valuation to insolvency: Insurtech startup Sproutt heading for bankruptcy
18:56
April 2024 in Israeli tech funding: Over $1 billion in 20 deals
16:00
Remepy raises $10 million Seed round to bring first hybrid drug to market
15:03
Full list of Israeli high-tech funding rounds in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
Cyber startup Oasis secures $35 million Series A extension, doubles valuation
3
"Israel definitely needs to reconsider its strategy towards China"
4
Cyber startup Island doubles valuation to $3 billion in $175 million Series D
5
De Niro to pro-Palestinian protestors: Stop talking nonsense, go home!
More news
Mapi Pharma
2 stories about Mapi Pharma
Copaxone-Competitor Developer Mapi Pharma Gets Funding for Jerusalem Plant
19.03.19
|
Lilach Baumer
The clinical-stage company develops more efficient versions of existing successful drugs, including a long-acting version of Teva's multiple sclerosis cash cow
Drug Developer Mapi Pharma Raises $10 Million from China's Jingxin Pharm
06.11.18
|
Lilach Baumer
The Xinchang, China-headquartered generic drugmaker is an existing investor, having made an initial $10 million investment in Mapi in 2016
Please ensure Javascript is enabled for purposes of
website accessibility